MARIA WEBER: Open Payments
NPI 1861972747 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 22 payments from 10 companies in 2025. Trend: 2023 $29 · 2024 $1,132 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $128 |
| ABBVIE INC. | 5 | $103 |
| Arcutis Biotherapeutics, Inc. | 2 | $31 |
| Galderma Laboratories, L.P. | 2 | $29 |
| UCB, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: OPZELURA, COSENTYX, RINVOQ, SKYRIZI, Zoryve, NEMLUVIO, Bimzelx, XOLAIR.
Industry payments across NY — which companies pay providers there.
